| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2021 | D2G ONCOLOGY, INC. | 353 LOWELL AVE | PALO ALTO | CA | 94301 | SANTA CLARA | USA | Cancer Treatment Research | 000 | 2 | 10/20/2022 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $865,070 ) |
| 2021 | 2021 | D2G ONCOLOGY, INC. | 353 LOWELL AVE | PALO ALTO | CA | 94301 | SANTA CLARA | USA | Cancer Treatment Research | 000 | 2 | 8/26/2021 | NON-COMPETING CONTINUATION | $865,070 |
|
| Issue Date FY: 2020 ( Subtotal = $1,134,487 ) |
| 2020 | 2020 | D2G ONCOLOGY, INC. | 353 LOWELL AVE | PALO ALTO | CA | 94301 | SANTA CLARA | USA | Cancer Treatment Research | 000 | 1 | 9/8/2020 | NEW | $1,134,487 |
|
|